Status:

COMPLETED

Personalised Exercise Training in COPD

Lead Sponsor:

Loughborough University

Conditions:

COPD

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

Exercise training as part of Pulmonary Rehabilitation (PR) has been shown conclusively to improve breathlessness,quality of life and exercise capacity for people with COPD. However generally PR is del...

Detailed Description

Chronic obstructive pulmonary disease (COPD) is a highly prevalent condition affecting an estimated 1.2 million people in the UK and is the second most common lung disease after asthma. COPD not only ...

Eligibility Criteria

Inclusion

  • Male or Female, aged 40 years or above
  • Diagnosis of COPD
  • FEV1/FVC \<0.7 and FEV1 \< 80% predicted
  • Medical Research Council (MRC) dyspnoea scale ≥3
  • Participant is willing and able to give informed consent for participation in the study.
  • Stable dose of current regular medication for at least 4 weeks prior to study entry.
  • Participant has clinically acceptable ECG at enrolment.
  • Able (in the Investigators opinion) and willing to comply with all study requirements.
  • English speaking

Exclusion

  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
  • Any major or uncontrolled comorbidity that would impair the participant's ability to exercise or would mean exercise was unsafe.
  • Participants who have participated in another research study involving an investigational product in the past 12 weeks
  • Participation in pulmonary rehabilitation in the preceding 6 months
  • Participation in another research study involving exercise training in the preceding 6 months
  • Acute exacerbation in the preceding 4 weeks (would become eligible 4 weeks following recovery)
  • Scheduled elective surgery or other procedures requiring general anaesthesia during the study.

Key Trial Info

Start Date :

October 3 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 2 2019

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT03817294

Start Date

October 3 2018

End Date

August 2 2019

Last Update

September 9 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Loughborough University

Loughborough, United Kingdom, LE11 3TU